US Stock MarketDetailed Quotes

Jyong Biotech (MENS)

Watchlist
  • 1.600
  • 0.0000.00%
Close Jun 17 15:59 ET
  • 1.640
  • +0.040+2.50%
Post 19:59 ET
121.64MMarket Cap-26.23P/E (TTM)

Jyong Biotech (MENS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(FY)Dec 31, 2024
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Total revenue
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
26.80%2.61M
-26.49%2.06M
-1.13%2.8M
17.68%2.83M
2.4M
Selling and administrative expenses
58.90%1.79M
-34.59%1.13M
12.15%1.73M
82.13%1.54M
--845K
-Selling and marketing expense
2.27%45K
-6.38%44K
0.00%47K
-12.96%47K
--54K
-General and administrative expense
61.20%1.75M
-35.38%1.09M
12.53%1.68M
88.62%1.49M
--791K
Research and development costs
-12.30%813K
-13.45%927K
-16.98%1.07M
-17.25%1.29M
--1.56M
Operating profit
-26.80%-2.61M
26.49%-2.06M
1.13%-2.8M
-17.68%-2.83M
-2.4M
Net non-operating interest income expense
-87.65%-1.93M
-46.65%-1.03M
7.76%-701K
8.32%-760K
-829K
Non-operating interest income
8,614.29%610K
-87.50%7K
1,020.00%56K
-16.67%5K
--6K
Non-operating interest expense
145.31%2.54M
36.72%1.04M
-1.05%757K
-8.38%765K
--835K
Other net income (expense)
-307.69%-135K
107.21%65K
70.34%-902K
-215.13%-3.04M
-965K
Other non- operating income (expenses)
-307.69%-135K
107.21%65K
70.34%-902K
-215.13%-3.04M
---965K
Income before tax
-54.72%-4.67M
31.39%-3.02M
33.63%-4.4M
-57.93%-6.63M
-4.2M
Income tax
0
0
0
0
0
Net income
-54.72%-4.67M
31.39%-3.02M
33.63%-4.4M
-57.93%-6.63M
-4.2M
Net income continuous Operations
-54.72%-4.67M
31.39%-3.02M
33.63%-4.4M
-57.93%-6.63M
---4.2M
Minority interest income
Net income attributable to the parent company
-54.72%-4.67M
31.39%-3.02M
33.63%-4.4M
-57.93%-6.63M
-4.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-54.72%-4.67M
31.39%-3.02M
33.63%-4.4M
-57.93%-6.63M
-4.2M
Basic earnings per share
-51.10%-0.06
31.39%-0.0397
33.63%-0.0579
-57.93%-0.0872
-0.0552
Diluted earnings per share
-51.10%-0.06
31.39%-0.0397
33.63%-0.0579
-57.93%-0.0872
-0.0552
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(FY)Dec 31, 2024(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Total revenue 00000
Operating revenue --0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 26.80%2.61M-26.49%2.06M-1.13%2.8M17.68%2.83M2.4M
Selling and administrative expenses 58.90%1.79M-34.59%1.13M12.15%1.73M82.13%1.54M--845K
-Selling and marketing expense 2.27%45K-6.38%44K0.00%47K-12.96%47K--54K
-General and administrative expense 61.20%1.75M-35.38%1.09M12.53%1.68M88.62%1.49M--791K
Research and development costs -12.30%813K-13.45%927K-16.98%1.07M-17.25%1.29M--1.56M
Operating profit -26.80%-2.61M26.49%-2.06M1.13%-2.8M-17.68%-2.83M-2.4M
Net non-operating interest income expense -87.65%-1.93M-46.65%-1.03M7.76%-701K8.32%-760K-829K
Non-operating interest income 8,614.29%610K-87.50%7K1,020.00%56K-16.67%5K--6K
Non-operating interest expense 145.31%2.54M36.72%1.04M-1.05%757K-8.38%765K--835K
Other net income (expense) -307.69%-135K107.21%65K70.34%-902K-215.13%-3.04M-965K
Other non- operating income (expenses) -307.69%-135K107.21%65K70.34%-902K-215.13%-3.04M---965K
Income before tax -54.72%-4.67M31.39%-3.02M33.63%-4.4M-57.93%-6.63M-4.2M
Income tax 00000
Net income -54.72%-4.67M31.39%-3.02M33.63%-4.4M-57.93%-6.63M-4.2M
Net income continuous Operations -54.72%-4.67M31.39%-3.02M33.63%-4.4M-57.93%-6.63M---4.2M
Minority interest income
Net income attributable to the parent company -54.72%-4.67M31.39%-3.02M33.63%-4.4M-57.93%-6.63M-4.2M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -54.72%-4.67M31.39%-3.02M33.63%-4.4M-57.93%-6.63M-4.2M
Basic earnings per share -51.10%-0.0631.39%-0.039733.63%-0.0579-57.93%-0.0872-0.0552
Diluted earnings per share -51.10%-0.0631.39%-0.039733.63%-0.0579-57.93%-0.0872-0.0552
Dividend per share
Currency Unit USDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On June 18, 2026, U.S. President Trump announced that a U.S.-Iran memorandum of understanding had been signed at the Palace of Versailles, w Show More